Literature DB >> 11485168

Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases.

M Ceruti1, G Balliano, F Rocco, P Milla, S Arpicco, L Cattel, F Viola.   

Abstract

Various vinyl sulfide and ketene dithioacetal derivatives of truncated 2,3-oxidosqualene were developed. These compounds, having the reactive functions at positions C-2, C-15 and C-19 of the squalene skeleton, were studied as inhibitors of pig liver and Saccharomyces cerevisiae oxidosqualene cyclases (OSC) (EC 5.4.99.7) and of Alicyclobacillus acidocaldarius squalene hopene cyclase (SHC) (EC 5.4.99.-). They contain one or two sulfur atoms in alpha-skeletal position to carbons considered to be cationic during enzymatic cyclization of the substrate and should strongly interact with enzyme nucleophiles of the active site. Most of the new compounds are inhibitors of the OSC and of SHC, with various degrees of selectivity. The methylthiovinyl derivative, having the reactive group at position 19, was the most potent and selective inhibitor of the series toward S. cerevisiae OSC, with a concentration inhibiting 500% of the activity of 50 nM, while toward the animal enzyme it was 20 times less potent. These results could offer new insight for the design of antifungal drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485168     DOI: 10.1007/s11745-001-0767-8

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  25 in total

1.  2,3,18,19-Dioxidosqualene Stereoisomers: Characterization and Activity as Inhibitors of Purified Pig Liver 2,3-Oxidosqualene-Lanosterol Cyclase.

Authors:  José-Luis Abad; Marisa Guardiola; Josefina Casas; Francisco Sánchez-Baeza; Angel Messeguer
Journal:  J Org Chem       Date:  1996-10-18       Impact factor: 4.354

2.  Purification of 2,3-oxidosqualene cyclase from rat liver.

Authors:  W R Moore; G L Schatzman
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

3.  Sequence of the Candida albicans erg7 gene.

Authors:  C A Roessner; C Min; S H Hardin; L W Harris-Haller; J C McCollum; A I Scott
Journal:  Gene       Date:  1993-05-15       Impact factor: 3.688

4.  A specific amino acid repeat in squalene and oxidosqualene cyclases.

Authors:  K Poralla; A Hewelt; G D Prestwich; I Abe; I Reipen; G Sprenger
Journal:  Trends Biochem Sci       Date:  1994-04       Impact factor: 13.807

5.  Identification and characterization of major lipid particle proteins of the yeast Saccharomyces cerevisiae.

Authors:  K Athenstaedt; D Zweytick; A Jandrositz; S D Kohlwein; G Daum
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

6.  Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.

Authors:  I Abe; M Bai; X Y Xiao; G D Prestwich
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

7.  The squalene-2,3-epoxide cyclase as a model for the development of new drugs.

Authors:  L Cattel; M Ceruti; F Viola; L Delprino; G Balliano; A Duriatti; P Bouvier-Navé
Journal:  Lipids       Date:  1986-01       Impact factor: 1.880

8.  Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.

Authors:  F Viola; P Brusa; G Balliano; M Ceruti; O Boutaud; F Schuber; L Cattel
Journal:  Biochem Pharmacol       Date:  1995-09-07       Impact factor: 5.858

9.  Inhibition of 2,3-oxidosqualene cyclases.

Authors:  M Taton; P Benveniste; A Rahier; W S Johnson; H T Liu; A R Sudhakar
Journal:  Biochemistry       Date:  1992-09-01       Impact factor: 3.162

10.  Non-specific biosynthesis of gammacerane derivatives by a cell-free system from the protozoon Tetrahymena pyriformis. Conformations of squalene, (3S)-squalene epoxide and (3R)-squalene epoxide during the cyclization.

Authors:  P Bouvier; Y Berger; M Rohmer; G Ourisson
Journal:  Eur J Biochem       Date:  1980-12
View more
  7 in total

1.  Stereoselective chlorothiolation of artemisinin-derived C-10 oxa terminal alkynes.

Authors:  Naresh Surineni; Pori Buragohain; Nabin C Barua
Journal:  Mol Divers       Date:  2015-06-19       Impact factor: 2.943

2.  Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase.

Authors:  Maurizio Ceruti; Gianni Balliano; Flavio Rocco; Alexander Lenhart; Georg E Schulz; Francesco Castelli; Paola Milla
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

3.  Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910·Na (Rigosertib®), a phase III clinical stage anti-cancer agent.

Authors:  Venkat R Pallela; Muralidhar R Mallireddigari; Stephen C Cosenza; Balaiah Akula; D R C Venkata Subbaiah; E Premkumar Reddy; M V Ramana Reddy
Journal:  Org Biomol Chem       Date:  2013-02-06       Impact factor: 3.876

4.  Conjugated methyl sulfide and phenyl sulfide derivatives of oxidosqualene as inhibitors of oxidosqualene and squalene-hopene cyclases.

Authors:  Flavio Rocco; Simonetta Oliaro Bosso; Franca Viola; Paola Milla; Giorgio Roma; Giancarlo Grossi; Maurizio Ceruti
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

5.  Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.

Authors:  Simonetta Oliaro-Bosso; Maurizio Ceruti; Gianni Balliano; Paola Milla; Flavio Rocco; Franca Viola
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

6.  Nano copper oxide catalyzed synthesis of symmetrical diaryl sulfides under ligand free conditions.

Authors:  K Harsha Vardhan Reddy; V Prakash Reddy; A Ashwan Kumar; G Kranthi; Yvd Nageswar
Journal:  Beilstein J Org Chem       Date:  2011-06-30       Impact factor: 2.883

7.  Characterization of the channel constriction allowing the access of the substrate to the active site of yeast oxidosqualene cyclase.

Authors:  Simonetta Oliaro-Bosso; Giulia Caron; Silvia Taramino; Giuseppe Ermondi; Franca Viola; Gianni Balliano
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.